KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Cost of Revenue: 2009-2024

Historic Cost of Revenue for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $2.3 billion.

  • Charles River Laboratories International's Cost of Revenue rose 0.69% to $572.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year increase of 15.36%. This contributed to the annual value of $2.3 billion for FY2024, which is 2.17% up from last year.
  • Latest data reveals that Charles River Laboratories International reported Cost of Revenue of $2.3 billion as of FY2024, which was up 2.17% from $2.3 billion recorded in FY2023.
  • Charles River Laboratories International's 5-year Cost of Revenue high stood at $2.3 billion for FY2024, and its period low was $1.5 billion during FY2020.
  • For the 3-year period, Charles River Laboratories International's Cost of Revenue averaged around $2.3 billion, with its median value being $2.3 billion (2023).
  • Data for Charles River Laboratories International's Cost of Revenue shows a peak YoY increased of 19.84% (in 2021) over the last 5 years.
  • Over the past 5 years, Charles River Laboratories International's Cost of Revenue (Yearly) stood at $1.5 billion in 2020, then increased by 19.84% to $1.8 billion in 2021, then increased by 16.64% to $2.1 billion in 2022, then increased by 7.12% to $2.3 billion in 2023, then rose by 2.17% to $2.3 billion in 2024.